Description
GLISOT-2 Tablet contains Glimepiride 2 mg, an oral antidiabetic medicine belonging to the sulfonylurea class. It is prescribed alongside diet and exercise to help improve blood glucose control in adults with type 2 diabetes mellitus when considered appropriate by a qualified healthcare professional. Glimepiride stimulates insulin release from pancreatic beta cells, helping reduce elevated blood glucose levels.
Glimepiride 2 mg may be included in an individualized diabetes management plan, either alone or alongside selected glucose-lowering medicines when clinically appropriate. Regular blood glucose monitoring, balanced meals, physical activity and medical follow-up remain essential components of diabetes care. This medicine is not intended to treat type 1 diabetes or diabetic ketoacidosis.
CardianCare focuses on cardiac and diabetic healthcare products for healthcare professionals and pharmaceutical business partners. Businesses searching for a Glimepiride 2 mg Tablets manufacturer India can enquire about current product availability, approved specifications and applicable quality documentation.
For procurement teams evaluating a Glimepiride 2 mg Tablets manufacturer and supplier India, important considerations include composition accuracy, product authorization, manufacturing source, batch traceability, packaging, shelf life and commercial supply terms.
2. Key Ingredient
Composition:
Glimepiride 2 mg
Glimepiride is an oral antidiabetic medicine classified as a sulfonylurea. It stimulates insulin secretion from pancreatic beta cells, helping the body reduce elevated blood glucose levels in adults with type 2 diabetes.
Unlike antidiabetic agents that mainly reduce glucose production in the liver or increase glucose excretion through urine, Glimepiride promotes insulin release. This mechanism can cause hypoglycaemia, particularly when meals are missed, calorie intake is reduced or other glucose-lowering medicines are used.
Businesses researching a Glimepiride 2 mg pharmaceutical company India should assess the product’s approved composition, labelling, manufacturing authorization, quality systems and relevant regulatory documentation.
Companies seeking a Glimepiride 2 mg medicine manufacturer India should verify the manufacturing source, product authorization, batch documentation and applicable quality requirements before entering into a supply arrangement.
3. Key Benefits
Blood glucose management: Helps improve glycaemic control in adults with type 2 diabetes when prescribed appropriately.
Insulin secretion support: Stimulates insulin release from pancreatic beta cells.
established antidiabetic class: Belongs to the sulfonylurea class of oral glucose-lowering medicines.
Oral treatment option: Provides a Tablet-based treatment option for eligible patients.
Individualized treatment planning: The strength can be considered by a prescriber according to the patient’s clinical needs and treatment response.
Comprehensive diabetes care: Can form part of a management plan that includes dietary measures, physical activity and regular blood glucose monitoring.
Clinical response varies with individual health status, meal patterns, other medicines and treatment adherence. The 2 mg strength is not suitable for every patient, and the risk of low blood glucose must be considered by the prescriber.
Pharmaceutical buyers searching for a Glimepiride 2 mg supplier India should verify product authenticity, availability, batch details, shelf life and relevant documentation before procurement.
A Glimepiride 2 mg Tablet wholesaler and distributor India enquiry may cover product availability, distribution eligibility, order requirements, delivery arrangements and applicable commercial terms.
Businesses looking for a Glimepiride 2 mg bulk supplier India should request relevant product information and confirm packaging specifications, expiry details, storage requirements and supply conditions.
A Glimepiride 2 mg pharmaceutical distributor India should verify product authorization, maintain appropriate storage and distribution practices, and communicate using approved product information.
4. How Does It Work?
Glimepiride stimulates insulin release from pancreatic beta cells. It binds to sulfonylurea receptors associated with ATP-sensitive potassium channels, promoting channel closure and changes in the cell membrane potential. This triggers calcium entry into the cells and stimulates insulin secretion.
The released insulin helps body tissues take up glucose from the bloodstream, contributing to improved blood glucose control in people with type 2 diabetes.
Because Glimepiride stimulates insulin release, it can cause hypoglycaemia, especially when meals are skipped, calorie intake is reduced, alcohol is consumed or other glucose-lowering medicines are taken. Treatment should be individualized and monitored by a qualified healthcare professional.
5. Directions for Use
Dosage: Take only as prescribed by a doctor. The appropriate dose depends on blood glucose levels, meal patterns, other medicines and individual clinical factors.
Administration: Follow the approved product label and the prescriber’s instructions. Glimepiride is commonly taken with breakfast or the first main meal of the day.
Regular timing: Follow the prescribed schedule consistently and do not change the dose without medical advice.
Meals: Do not skip meals after taking the medicine, as this can increase the risk of hypoglycaemia.
Blood glucose monitoring: Monitor blood glucose as recommended by the treating clinician.
Missed dose: Follow the patient information leaflet or ask a doctor or pharmacist. Do not take a double dose to compensate for a missed dose.
Lifestyle management: Continue recommended dietary measures, physical activity and follow-up appointments.
Dose adjustment: Any change in dose should be made by the prescriber according to treatment response and the risk of low blood glucose.
The 2 mg strength is not necessarily the correct dose for every patient. Follow the approved product information and individualized medical advice.
6. Possible Side Effects
Possible side effects associated with Glimepiride include:
Hypoglycaemia or low blood glucose.
Sweating, shakiness, dizziness or sudden hunger.
Headache or weakness.
Nausea or other gastrointestinal discomfort.
Temporary visual disturbances, particularly when blood glucose levels change.
Weight gain in some patients.
Allergic skin reactions in some individuals.
Seek urgent medical attention for severe hypoglycaemia, confusion, seizures, loss of consciousness or symptoms of a serious allergic reaction, including facial swelling or difficulty breathing.
This list is not exhaustive. Patients should seek professional advice about persistent or concerning symptoms.
7. Safety Information
Medical supervision: Use only under the guidance of a qualified healthcare professional.
Type 1 diabetes: Glimepiride is not intended to treat type 1 diabetes or diabetic ketoacidosis.
Hypoglycaemia: The risk increases with skipped meals, fasting, reduced calorie intake, strenuous exercise, alcohol and certain drug interactions.
Kidney function: Patients with impaired kidney function may be more vulnerable to hypoglycaemia and require careful medical assessment and dose selection.
Liver health: Inform the doctor about liver disease, as it may affect treatment suitability and adverse-effect risk.
Pregnancy: Consult a doctor before use during pregnancy or when planning pregnancy. The clinician should determine the most appropriate diabetes treatment.
Breastfeeding: Seek medical advice before use while breastfeeding because treatment suitability and potential infant risks need assessment.
Drug interactions: Inform the prescriber about all prescription medicines, over-the-counter products and supplements. Some medicines can increase or reduce Glimepiride’s glucose-lowering effect.
Alcohol: Alcohol may affect blood glucose control and increase the risk of adverse reactions. Discuss alcohol use with the treating clinician.
Driving and machinery: Hypoglycaemia can impair concentration and reaction time. Patients should understand their individual risk before driving or operating machinery.
Storage: Store in the original packaging according to the approved product label, protected from excessive heat and moisture and out of children’s reach.
This information is educational and does not replace approved prescribing information or individualized medical advice.
8. B2B Pharmaceutical Business Enquiries
CardianCare focuses on cardiac and diabetic healthcare products for healthcare professionals and pharmaceutical business partners. Distributors, wholesalers, pharmacists and procurement teams can enquire directly about current product availability and applicable commercial arrangements.
Businesses searching for a Glimepiride 2 mg PCD pharma franchise India opportunity should confirm whether the product is available through a current programme. Territory availability, partner eligibility, product range and commercial terms require direct verification.
For a Glimepiride 2 mg Tablets PCD pharma franchise enquiry, prospective partners may request information about eligible products, applicable order requirements, distribution conditions and approved promotional materials.
Companies exploring a Glimepiride 2 mg Tablet PCD franchise should verify product and programme availability before making investment or promotional commitments.
Businesses researching Glimepiride 2 mg third party manufacturing India should confirm whether the proposed company offers these services. If applicable, due diligence should include manufacturing permissions, product approvals, applicable GMP compliance, quality agreements and batch-release procedures.
A Glimepiride 2 mg Tablet third party manufacturer India enquiry should cover manufacturing authorization, formulation specifications, quality control, packaging requirements, batch documentation and contractual responsibilities.
Companies investigating Glimepiride 2 mg contract manufacturing India should verify service availability and assess regulatory responsibilities, quality agreements, manufacturing authorization, technical documentation, minimum batch quantities and commercial feasibility.
Visit https://CardianCare.com/ to contact CardianCare regarding current product availability, pharmaceutical business enquiries and applicable arrangements. Franchise, distribution and manufacturing services must be confirmed directly with the company before being represented as available.
For more information about GLISOT-2 Tablet (Glimepiride 2 mg), click here












Reviews
There are no reviews yet.